Regeneron Down Over 16%, On Track for Largest Percent Decrease Since April 2011 -- Data Talk

Dow Jones
05-30

Regeneron Pharmaceuticals, Inc. $(REGN)$ is currently at $503.78, down $101.61 or 16.78%

 

--Would be lowest close since June 1, 2021, when it closed at $503.23

--On pace for largest percent decrease since April 29, 2011, when it fell 21%

--Currently down five of the past seven days

--Down 15.86% month-to-date; on pace for worst month since Oct. 2024, when it fell 20.27%

--Down 29.28% year-to-date

--Down 58.08% from its all-time closing high of $1201.76 on Aug. 27, 2024

--Down 48.60% from 52 weeks ago (May 31, 2024), when it closed at $980.16

--Down 58.08% from its 52-week closing high of $1201.76 on Aug. 27, 2024

--Would be a new 52-week closing low

--Traded as low as $493.15; lowest intraday level since May 27, 2021, when it hit $492.13

--Down 18.54% at today's intraday low; largest intraday percent decrease since April 29, 2011, when it fell as much as 21.45%

--Worst performer in the S&P 500 today

--Worst performer in the Nasdaq 100 today

 

All data as of 10:20:21 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

May 30, 2025 10:23 ET (14:23 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10